Interested in being part of a final COVID-19 vaccine trial?

OHSU is seeking residents in or near the Portland Metro area (living within approximately 1.5 hours of OHSU's clinic)to participate in Phase 3 clinical trial. Astra Zeneca, one of the three pharmaceutical companies with a vaccine that’s close to being final, is working with OHSU for the trial, its only site in Oregon. 

Trial participants must be 18 or older, not be pregnant, have either stable medical conditions or no medical issues, have not been previously diagnosed with COVID-19, and should live within approximately 1.5 hours of OHSU’s Marquam Hill/South Waterfront campus in Portland, among other criteria. Participants will be monitored for two years.

OHSU wants COVID-19 vaccines to work well for the broadest group of people possible, and particularly for communities that have been hardest hit by the coronavirus pandemic. The study strives to enroll a diverse group of participants, and prioritizes enrollment of individuals who are older than 55 and Black, Indigenous and People of Color.

Remember, it’s not guaranteed that you’ll get the actual vaccine—as is usual in a blind study, you may well get a placebo.

Learn more from OHSU here. If interested in enrolling in the trial, apply here or call 888-VAC-STDY (888-822-7839).